Condition: Vivax Malaria · G6PD Deficiency · Sponsor: Menzies School of Health Research
A non randomized observation study that is aiming to assess the safety and efficacy of high dose primaquine (1mg/kg per day over 7 days) among patients with intermediate (30-70%) G6PD activity and the safety and efficacy of weekly primaquine among patients who are g6Pd deficient (\<30% activity)
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Dr Marcus Lacerda | Manaus, Brazil | Recruiting |
| Arba Minch General Hospital | Arba Minch, Ethiopia | Not Yet Recruiting |
| Dr Moses Laman and Dr Brioni Moore | Alexishafen, Madang Province, Papua New Guinea | Recruiting |
| Papua New Guinea Institute of Medical Research | Port Moresby, Magang, Papua New Guinea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07468513